CANADA LIFE ASSURANCE Co - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 102 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2018. The put-call ratio across all filers is 2.89 and the average weighting 1.0%.

Quarter-by-quarter ownership
CANADA LIFE ASSURANCE Co ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2018$24,000
-17.2%
10,2750.0%0.00%
Q4 2017$29,0000.0%10,2750.0%0.00%
Q3 2017$29,000
+16.0%
10,2750.0%0.00%
Q2 2017$25,000
-32.4%
10,2750.0%0.00%
Q1 2017$37,0000.0%10,2750.0%0.00%
Q4 2016$37,000
-54.9%
10,275
-50.0%
0.00%
Q3 2016$82,000
+82.2%
20,550
+100.0%
0.00%
Q2 2016$45,000
+15.4%
10,2750.0%0.00%
Q1 2016$39,000
-75.8%
10,2750.0%0.00%
-100.0%
Q4 2015$161,000
+47.7%
10,2750.0%0.00%
Q3 2015$109,000
-57.9%
10,2750.0%0.00%
-100.0%
Q2 2015$259,000
-9.4%
10,2750.0%0.00%0.0%
Q1 2015$286,000
+52.9%
10,2750.0%0.00%0.0%
Q4 2014$187,000
+39.6%
10,2750.0%0.00%
Q3 2014$134,000
+91.4%
10,275
+139.0%
0.00%
Q2 2014$70,000
-6.7%
4,3000.0%0.00%
Q1 2014$75,000
-28.6%
4,3000.0%0.00%
Q4 2013$105,0004,3000.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q2 2018
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 844,981$15,421,0007.11%
DOHENY ASSET MANAGEMENT /CA 195,345$3,565,0001.70%
First Light Asset Management, LLC 153,617$2,804,0001.59%
Rhenman & Partners Asset Management AB 175,000$3,194,0000.93%
Iguana Healthcare Management, LLC 100,000$1,825,0000.88%
Eventide Asset Management 288,700$5,269,0000.58%
Bedell Frazier Investment Counselling, LLC 60,820$1,110,0000.54%
STONERIDGE INVESTMENT PARTNERS LLC 214,327$3,911,0000.52%
Fernwood Investment Management, LLC 31,350$572,0000.49%
SUFFOLK CAPITAL MANAGEMENT LLC 168,560$3,076,0000.37%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders